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Abstract 
Introduction: The perimenopausal age is a time of many changes in women’s health. Changes in women’s 
health affect all spheres of life, because health is not merely the absence of disease or infirmity but full psy-
chological, physical and social well-being. Presentation and comparison of the biopsychosocial functioning of 
women of different races and nationalities in perimenopause, identification of the most common menopause 
symptoms occurring among women and their needs.
Material and methods: Work supported with research examples. Using the PubMed database, the medical 
literature was searched for works that contain the key words menopause and race or ethnicity published be-
tween 1996 and 2013 and available in English. Literature in Polish is a supplementary issue. 
Results: Various demographic processes taking place in the countries of Africa, North and South America, 
Asia and Europe are the basis for observing the situation in perimenopausal women in these countries. Cauca-
sian women living in North America and Europe most often experience the negative symptoms of menopause, 
hindering daily functioning, and women living in urbanized countries in Asia best assess their health condition, 
both psychosocial and physical. 
Conclusions: Biopsychosocial functioning of women varies among countries. Developing countries should 
be given the necessary support and financial information to ensure the health and quality of life in perimeno-
pausal women. In most countries of the world there has been observed the need to promote women’s health, 
particularly research aimed at prevention, increasing physical activity and attention to nutrition. 
Key words: perimenopausal age, menopause, biopsychosocial functioning. 
Introduction
The perimenopausal period of women is a time of 
many changes in biopsychosocial functioning. Some-
times, it even lasts for 15 consecutive years, from 45 
years of age. The World Health Organization has di-
vided the menopausal life of women into three periods 
surrounding menopause. The first is the menopau-
sal transition period (premenopause), characterized 
by irregular menstrual age and generally about 45 to 
49 years of age. Perimenopause lasts for about 2 years 
before menopause and up to 2 years after menopause. 
During this period, the first biological and endocrine 
symptoms appear. Postmenopause is the time after 
the last menstruation, irrespective of whether the 
menopause was a natural process or was induced ar-
tificially [1]. 
Interest in menopause increased with the increase 
in the average life expectancy of women and the de-
mographic reality, concerning a surplus of women over 
men in the world’s population [2]. Of great importance 
in the case of biopsychosocial functioning of women in 
the perimenopausal period are ageing societies, often 
called nowadays “graying continents” [3]. Not without 
significance are other demographic changes in the in-
dividual countries, such as decline in the birth rate, the 
increasing age of women giving birth, and changes in 
family structure. The growing trend for their own health 
care and the cult of beauty of the human body have 
found many followers, and the epidemiological statis-
tics as well as the results of numerous scientific studies 
confirm the increasing problems that pose a challenge 
to public health on a global basis. 
The main objective is to present the differences in 
the changes in the symptoms occurring in the perimen-
opausal period in women from different countries and 
continents. The study is also intended to indicate the 
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variety of factors determining the course of the peri-
menopausal period.
Material and methods 
Using the PubMed database, the medical literature 
was searched for works that contain the key words 
menopause and race or ethnicity published in the years 
1996-2013 and available in English. Due to the large 
number of papers that meet the above criteria, we se-
lected those which in a  transparent manner present 
data based on studies conducted among women of 
different races and nationalities. More than 40 foreign 
articles were selected that closely meet the selection 
criteria; 7 of them concern perimenopausal women 
from Asian countries, 3 articles relate to African coun-
tries, and the situation in perimenopausal women in 
countries in the America are presented on the basis 
of 4 articles. Among the articles presenting the func-
tioning of women in Europe, 7 were selected, while the 
situation of women in Poland is presented on the basis 
of 5 articles published in the “Menopause Review”. In 
close connection with the subject of the work, we also 
present current ways to relieve menopausal symptoms, 
by means of 12 foreign and Polish articles (PubMed 
database). Other items of literature are on similar is-
sues concerning demographic change in Europe. These 
works are complementary issues.
Results
The last few years all over the world have seen a con-
tinuation of colossal demographic changes. The grow-
ing number and proportion of older people is due to 
the low birth rate and low mortality [4]. Demographic 
processes of change are taking place faster in develop-
ing countries than in developed countries [5]. The new 
demographics, formed in Europe in the 1990s, is char-
acterized by a significant reduction in fertility, increase 
of illegitimate births, and a growing number of partners 
in a consensual union [6]. 
A review of the literature shows that the number of 
studies conducted in African countries is the smallest 
one. Menopause is seen by African women as a time of 
“relief” from pregnancy and motherhood, but for wom-
en without children, this time begins with depressive 
disorders. African countries are highly diverse in terms 
of customs and cultural beliefs. In some cultures, wom-
en after menopause often strengthen their position 
in society, and then begin to be treated “on an equal 
footing” with men. In other cultures it is believed that 
postmenopausal menstrual bleeding is a negative sign 
– of being haunted, resulting in delayed medical treat-
ment [7]. Research in 1997 indicated the presence of an 
early perimenopausal period in African women, which 
is caused by the numerous children in quick succession. 
Symptoms of menopause in African women are not dif-
ferent from those typical for other women, but social 
and economic factors differ. Several authors are of the 
opinion that among African women in menopause there 
has not been observed an increase in the incidence of 
breast cancer. According to other researchers, 50% of 
detected cases of breast cancer affect women at a later 
period, i.e. menopause, indicating the malignant form 
of cancer [8]. 
African-American women do not perceive symp-
toms of menopause as problems for which women 
should consult a  doctor. Dark-skinned women think 
they are seen as being mentally strong and fully accept 
all the changes. Compared with Asian, Latin and Euro-
pean women, the most common problem for African 
women was to maintain a healthy body weight during 
menopause [9]. In addition, these women experience 
more inequality in access to health services due to 
limitations in health insurance. They have higher levels 
of poverty and disability, higher incidence of lifestyle 
diseases and a  shorter life expectancy. Among dark-
skinned women, there was a higher risk of heart failure 
compared with Asian and Latin women and women liv-
ing in areas of the Pacific [10]. African-American wom-
en’s knowledge about menopause, social support and 
the socio-economic situation is not comforting [11].
Since 1994, in Asian countries high rates of mortal-
ity from cardiovascular disease have been noted. These 
data indicators still lag behind those from the United 
States or the United Kingdom, but the Asian ones are 
becoming more challenging [12]. A common symptom 
perceived negatively by Asian women and unusual in 
studies of women of other nationalities was stiff joints 
[13]. The most common problems for women in Asia 
were insomnia and irritability (51%). Women in Asia 
occasionally look for advice concerning medication in 
treatment of symptoms of menopause. They more often 
use natural or herbal methods which – as proved by the 
study – are not characterized as being more effective 
than placebo [14]. There was also a negative attitude 
towards women taking hormone replacement therapy 
(43%), explaining their reluctance with the connection 
between the use of hormone replacement therapy and 
increased risk of breast cancer. Among Asian women in 
the perimenopausal period there is less interest in sex 
life and withdrawn satisfaction. Women experience dis-
comfort during intercourse, sometimes pain, which has 
a negative impact according to respondents on the rela-
tionship with their partner, quality of life and reduction 
of femininity. Most Asian women do not discuss their 
problems of a biological nature with their partners, and 
only 12% of women share their experiences with other 
women [15]. 
Another interesting study pointed out the connec-
tion between the consumption of isoflavones and soy, 
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and the alleviation of menopausal symptoms. A review 
of the current literature does not support the efficacy 
of alternative therapies in patients diagnosed with 
contraindications to hormone therapy or feared side ef-
fects of hormone treatment, to alleviate or eliminate pain 
symptoms of the menopausal period [16]. The authors 
of many studies have reported that phytoestrogens have 
a positive effect during menopause [17-20]. Herbs such as 
black cohosh, Chinese angelica, evening primrose or gin-
seng do not bring an improvement in relieving vasomotor 
symptoms [14, 21-23]. Researchers appreciate the posi-
tive impact of physical activity on weight reduction, which 
in turn can reduce the severity of menopausal symptoms. 
The most desirable form of activity for perimenopausal 
women is yoga, aerobics or swimming [24-26].
A  surprising result of the study was the fact that 
Asian women living in the United States assessed the 
menopausal period less positively than their fellow 
citizens remaining in Asia. In a  study of 105 women, 
including 50 women from the city of Mexico, and 55 
women from the state of Yucatan, it was observed that 
menopause symptoms were more severe for women 
living in metropolitan Mexico City, which may be af-
fected by dependence on Western culture [27].
Women living in big cities, educated and obtaining 
higher wages for work, remained sexually active longer 
[28]. Asians cope better with the symptoms of meno-
pause, with additional changes in lifestyle, relaxation, 
optimistic thinking and yoga. This helps in reducing 
mood swings [9]. 
Another report from 2007 provides information on 
the biopsychosocial functioning of women from India, 
Pakistan and China. Highly educated women living in 
urban cities were more susceptible to the symptoms of 
menopause than women with primary education, living 
in rural areas [29]. Research conducted in Pakistan by Ma-
lik reported that 94% of perimenopausal women do not 
see menopause as a medical problem, and only 1.96% 
of the women were afraid to use hormone replacement 
therapy. It should also be noted that 75.5% of women 
belonged to the socio-economically poor social stratum. 
Among women in India, there is a belief that the peri-
menopausal period is the “beginning of the end”, de-
termined by culture, religion and spiritual beliefs. About 
60% of Indian women aged 50 years are widows and 
suffering in the perimenopausal period from hysteria, 
anemia, osteoporosis, and poverty [30].
Research conducted in 2012 among women of dif-
ferent origins in Malaysia (including Indian women) 
found that studied individuals were characterized by 
a  closed attitude toward sexual need during meno-
pause, which leads to the consideration of the introduc-
tion of intervention programs in line with the Malaysian 
culture environment [31]. 
North and South America is inhabited by women 
of different races and ethnic groups. Hot flashes are 
a characteristic symptom of African-American women 
(67.8%) and women of the white race, mostly Ameri-
cans of European descent. Next, 52.5% of Latin women 
complain about hot flashes, compared to only 26.1% 
of Asian women. The other most frequently reported 
symptoms were pain in the muscles and bones, and 
problems with the urogenital system. In Latin America, 
most women reported trouble falling asleep. Higher re-
portability of any problems associated with menopause 
was reported in North America, comparable to data 
from Europe [32]. 
Women living in Europe feel the most numerous 
perimenopausal symptoms such as hot flashes, sleep 
disturbances [33] and urogenital system disorders. 
More than half of Swedish women after the age of 50 
experience hot flashes [34]. Lifestyle change to increase 
of physical activity is an alternative to the use of hor-
mone replacement therapy. Numerous scientific studies 
indicate a lower risk of cardiovascular disease with the 
frequent use of physical exercise, particularly in post-
menopausal women [35]. A study from Finland showed 
the danger of the use of hormone replacement therapy 
and the problems associated with mammography in 
the diagnosis of breast cancer. The risk was observed 
in the case of injection estrogen therapy or sequential 
estrogen-progesterone therapy [36]. 
Increasing attention is also paid to sexual func-
tioning in menopausal women. Studies in the United 
Kingdom from 2012 point to the urgent need for ex-
tensive research on the effects of replacement therapy 
on sexual desire. Postmenopausal British women are 
increasingly seeking help from specialists in diseases 
associated with sexual functioning [37].
Research from Poland does not show large differ-
ences in the prevalence of typical climacteric symptoms 
like those reported in Europe and in Caucasian women 
living in North America. There is an intensification of 
climacteric symptoms along with age, poor material 
circumstances, living alone and non-use of hormone 
therapy, which in turn affects the family and profession-
al relationships [38]. The worrying issue is the lack of 
physical activity of women. Active forms of recreation 
are often carried out by women who are more affluent. 
Nearly half of women will experience once in a while 
a variety of indispositions that cause discomfort, and 
14% say that they feel so bad that it makes their daily 
functioning harder [39]. Most perimenopausal women 
used dietary supplements and they do not have a nega-
tive attitude towards the use of hormone replacement 
therapy. 
In a study of 2013 from Poland 12,676 women aged 
45-69 years took part in Novosibirsk (Russia), Krakow 
(Poland) and six Czech cities. The aim of this study was 
to investigate the age of menopause in relation to socio-
economic, behavioral and health factors. Average age 
of menopause was 50 years in Novosibirsk, 51 years 
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in the Czech cities and 52 years in Krakow. Higher edu-
cation, taking dietary supplements and oral contracep-
tives were associated with a  later age of menopause, 
while smoking, low physical activity and refraining from 
alcohol were associated with an earlier onset of meno-
pause. Differences in age of occurrence of menopause 
between the countries of Central and Eastern Europe 
were significant and unexplained by a number of risk 
factors. The results were to a large extent in compliance 
with studies in other populations [40].
The position of the Panel of Experts of the Polish 
Menopause and Andropause Society in 2010 is clear 
and focuses on the practical aspects of treatment in the 
light of evidence-based medicine. In Poland there are 
about 9 million women over 46 years of age, in whom 
there is evidence for use of different forms of hormone 
therapy. Despite a decline in interest in HRT since 2002, 
in Poland there was a need to improve the current state 
of knowledge and individualization of therapy [41]. 
Despite much discussion, research and medical 
authorities meeting in 2012, there are still differences 
between the opinions of scientists on the use of re-
placement therapy [42]. Primarily, the individualiza-
tion of hormone replacement therapy is necessary [43]. 
Professional societies such as the International Meno-
pause Society (IMS), the European Menopause and An-
dropause Society (EMAS), and the Polish Menopause 
and Andropause Society (PTMA) currently recommend 
transdermal therapy as effective and safe [44-46].
The position of the Panel of Experts of the PTMA of 
2012, regarding the selection of the route of adminis-
tration in the treatment of menopausal hormones, in-
dicates that the percutaneous route has good efficacy 
and a favorable safety profile [41]. The North American 
Menopause Society (NAMS) does not state a clear ad-
vantage of any of the routes of administration of estro-
gen therapy [47].
Discussion and conclusions
Forecasts of anticipated changes suggest that in fu-
ture years the number of women in the menopausal 
age will increase. Systems of health and social care will 
be under-funded in many countries, which can cause 
numerous problems in access to services for women 
entering the perimenopausal period and force them to 
cope with menopausal symptoms on their own using 
the latest available methods. All demographic changes 
discussed above have an impact on the biopsychosocial 
functioning of women during perimenopause, and this 
should be the basis for the creation of efficient systems 
of care and support for women in different countries. 
The needs of women in developing countries and those 
in developed countries will be presented differently.
There are a  number of inconsistencies in the pro-
posed ways to prevent and treat symptoms of the pe-
rimenopausal period, so it is necessary to conduct fur-
ther in-depth research in this area. It is also necessary 
to provide information and financial support for devel-
oping countries to improve the quality of life of wom-
en and increase their average life expectancy. There 
is a  great need to promote a healthy lifestyle among 
perimenopausal women, in particular relaxation tech-
niques, increased physical activity, and healthy eating. 
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